Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO)

TWD 27.7

(2.59%)

Net Debt Summary of Chi Sheng Pharma & Biotech Co., Ltd

  • Chi Sheng Pharma & Biotech Co., Ltd's latest annual net debt in 2023 was -261.04 Million TWD , down -55.63% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd's latest quarterly net debt in 2024 Q2 was -180.53 Million TWD , down -100.18% from previous quarter.
  • Chi Sheng Pharma & Biotech Co., Ltd reported annual net debt of -165.87 Million TWD in 2022, down -515.43% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd reported annual net debt of 39.92 Million TWD in 2021, up 121.33% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd reported quarterly net debt of -180.53 Million TWD for 2024 Q2, down -100.18% from previous quarter.
  • Chi Sheng Pharma & Biotech Co., Ltd reported quarterly net debt of -92.02 Million TWD for 2023 Q3, up 57.72% from previous quarter.

Annual Net Debt Chart of Chi Sheng Pharma & Biotech Co., Ltd (2023 - 2019)

Historical Annual Net Debt of Chi Sheng Pharma & Biotech Co., Ltd (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -261.04 Million TWD -55.63%
2022 -165.87 Million TWD -515.43%
2021 39.92 Million TWD 121.33%
2020 -187.23 Million TWD -82.77%
2019 -102.44 Million TWD 0.0%

Peer Net Debt Comparison of Chi Sheng Pharma & Biotech Co., Ltd

Name Net Debt Net Debt Difference
St.Shine Optical Co.,Ltd. -1.4 Billion TWD 81.372%
Bioteque Corporation -459.67 Million TWD 43.21%
Sunder Biomedical Tech. Co., Ltd. 394.6 Million TWD 166.155%
BenQ Medical Technology Corporation 405.72 Million TWD 164.342%
Pacific Hospital Supply Co., Ltd -307.54 Million TWD 15.12%
Unicon Optical Co., Ltd. 41.06 Million TWD 735.651%
Formosa Optical Technology Co.,Ltd. 2.78 Billion TWD 109.378%
Medeon Biodesign, Inc. -1.19 Billion TWD 78.078%
Concord Medical Co., Ltd. 104.78 Million TWD 349.138%
Crystalvue Medical Corporation -248.31 Million TWD -5.126%
Perfect Medical Industry Co., Ltd. 50.55 Million TWD 616.397%
ICARES Medicus, Inc. -259.62 Million TWD -0.547%
Lagis Enterprise Co., Ltd. 87.79 Million TWD 397.336%
Amed Co., Ltd. 153.75 Million TWD 269.787%